Product Program year 2024 Source: CMS Open Payments

Quadra Allure MP

Device Cardiac Rhythm Management

PDI 05414734510097

Open in the dashboard

General payments

$39,678

800 payments

Research payments

$31,013

24 payments

Through program year 2024, $39,678 in general payments and $31,013 in research payments were reported against Quadra Allure MP (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $3,522 93
2023 General $6,776 197
2023 Research $1,100 2
2022 General $29,380 510
2022 Research $29,913 22

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $39,678 800 payments
Top recipients General payments · program year 2024
  1. Niraj Varma Cardiovascular Disease · Maywood, IL $1,875 53% · 2 payments
  2. Neelima Paladugu Clinical Cardiac Electrophysiology · Fort Worth, TX $99 3% · 1 payment
  3. Aakash Shah Cardiovascular Disease · Humble, TX $91 3% · 4 payments
  4. Suleyka Olivero-Rivera Clinical Cardiac Electrophysiology · Bayamon, PR $79 2% · 4 payments
  5. Mary Lim-Fung Clinical Cardiac Electrophysiology · Humble, TX $75 2% · 2 payments

The top 5 of 66 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Cardiovascular Disease Internal Medicine $2,249 64% · 14 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $651 18% · 24 practitioners
  3. Interventional Cardiology Internal Medicine $203 6% · 10 practitioners
  4. Nurse Anesthetist, Certified Registered $98 3% · 2 practitioners
  5. Physician Assistant $86 2% · 2 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Illinois $1,875 53% · 1 recipient
  2. Texas $537 15% · 22 recipients
  3. South Carolina $309 9% · 12 recipients
  4. Puerto Rico $159 5% · 4 recipients
  5. Michigan $147 4% · 3 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

800 general · 24 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record